Navigation Links
Boston Scientific Announces Schedule of Events at TCT Scientific Symposium
Date:11/1/2011

#160;Presentations will examine clinical data from challenging PCI subsets and preview new research on bioabsorbable drug delivery from the EVOLVE trial.
  • REPRISE Clinical Program for Lotus™ Valve System.  Ian Meredith, M.B.B.S., Ph.D., will present an update on the REPRISE clinical program, which is evaluating the Lotus™ Valve System, the first fully repositionable device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis.  The Lotus Valve was developed by Sadra Medical, acquired by Boston Scientific in 2011.  The spotlight session begins at 8:58 a.m. in Room 135.  

  • Friday, November 11

  • Late-Breaking Trial: EVOLVE Endpoint Data.  Principal Investigator Ian Meredith, M.B.B.S., Ph.D., will present primary endpoint data from the EVOLVE trial during a late-breaking clinical session at 11 a.m. in the Main Arena.  EVOLVE is a prospective, randomized, non-inferiority trial that compares two dose formulations of everolimus on Boston Scientific's SYNERGY Coronary Stent to the PROMUS Element Everolimus-Eluting Coronary Stent in patients with de novo coronary artery lesions.  The SYNERGY Stent features the Company's proprietary platinum chromium alloy and uses a bioabsorbable polymer and everolimus drug combination to create an ultra-thin, uniform coating confined to the outer surface of the stent.  The Company plans to issue a press release announcing trial results at the conclusion of the presentation.

  • Late-Breaking Trial: COBRA Endpoint Data.   Subhash Banerjee, M.D., will present 12-month endpoint data from the COBRA trial during a late-breaking clinical session at 12:40 p.m. in the Main Arena.  COBRA is a prospective, randomized, multi-center trial that compares CryoPlasty® Therapy using the PolarCath™ Peripheral Dilatation System to conventional balloon angioplasty for the post-dilatation of
    '/>"/>

  • SOURCE Boston Scientific Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
    3. Boston University Biomedical Engineers Find Chink in Bacterias Armor
    4. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
    5. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
    6. Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
    7. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
    8. Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
    9. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
    10. Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
    11. Boston Scientific Announces CE Mark Approval for New Devices to Treat Heart Failure and Sudden Cardiac Death
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/14/2014)... July 14, 2014  More than any other generation, Millennials ... tablet computers -- but their eyes don,t. These mobile devices ... before, and the eye has not evolved to cope with ... eyes can do comfortably often results in tired eyes, focusing ... Digital Eye Strain. Now ZEISS has invented a new type ...
    (Date:7/14/2014)... , July 14, 2014  Diomics, Inc., ... today announced that the United States Patent and ... by Diomics covering novel biologic sample collection materials, ... use in forensics and diagnostics. ... is by swabbing. Recovery of DNA from a ...
    (Date:7/14/2014)... Sinovac Biotech Ltd. (NASDAQ: SVA ), a leading ... that it will hold its 2014 Annual Meeting of Shareholders on Wednesday, ... held at No. 39 Shangdi Xi Road, Haidian District, Beijing ... will be eligible to vote and are invited to attend. ... Weidong Yin , Yuk Lam Lo , Simon Anderson ...
    Breaking Medicine Technology:New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 2New Eyeglass Lens Helps Our Eyes Keep Up with our Digital Lives 3Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2Sinovac Schedules 2014 Annual Meeting of Shareholders 2Sinovac Schedules 2014 Annual Meeting of Shareholders 3
    (Date:7/14/2014)... (PRWEB) July 14, 2014 The ... increasing demand for clean energy, initiatives of associations ... the major factors which drive the growth of ... metals are used in various direct applications ranging ... and x-rays, among others. , North America is ...
    (Date:7/14/2014)... 14, 2014)In the 2,500+ years that have passed ... Chinese, it has been used to treat a ... nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, ... just a few. Now, a meta-analysis of ... month in Menopause , the journal of ...
    (Date:7/14/2014)... There’s an old adage that says first ... Palette say the products offered in their preorder event ... can reserve The Lash Palette for $40,” said Jenelle Paris, ... , Paris explained that the first 1,000 have already been ... She went on to point out that her company is ...
    (Date:7/14/2014)... The governments in many countries are developing health ... Solutions market. For instance, in the US, Barack Obama's ... Clinical Health Act under the American Recovery and Reinvestment ... Global Mobile Health Solutions market will grow at ... According to the report, one of the prime drivers ...
    (Date:7/14/2014)... has entered into an agreement with one of ... novel drug candidates for the detection and treatment ... in novel antibody discovery and Roche,s expertise in ... the possibility of improved treatment for cancer, a ... collaboration makes use of BTI,s discovery of a ...
    Breaking Medicine News(10 mins):Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 2Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 3Health News:North America Rare Earth Metals Market is Expected to Grow at a CAGR of 8% - New Report by MicroMarket Monitor 4Health News:Bothered by hot flashes? Acupuncture might be the answer 2Health News:The Lash Palette Preorder Event Has Officially Begun 2Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 2Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 3Health News:Mobile Health Solutions Market to Grow at 34.88% CAGR by 2018, Says a New Research Report at Sandlerresearch.org 4Health News:A*STAR partners Roche to develop new cancer therapeutics 2
    ... Aug. 7 /Xinhua-PRNewswire-FirstCall/ -- Aamaxan,Transport Group, Inc. ... AAXT),through its subsidiaries, including Shanghai Medical Technology ... a leading provider of Hemodialysis,equipment ("HDE") and ... diagnostic products, throughout Eastern China, today,announced the ...
    ... (Nasdaq:,MITI), a biopharmaceutical company focusing on the development ... inflammation and,autoimmune diseases, today announced its financial results ... 30, 2008., Summary of Recent Events:, ... update for the,BiTE(R) antibody blinatumomab (MT103/MEDI-538) at the ...
    ... - Annual revenue increases 5 percent to ... 76 percent to $3.64 and 11 percent to ... $23 billion, GAAP diluted, earnings per share from continuing operations increase 51 percent ... and 9 percent to $0.97 on a non-GAAP basis ...
    ... Calif., Aug. 7 The Board of Directors,of Endocare, ... 2008 an unsolicited,proposal from HealthTronics, Inc. (Nasdaq: HTRN ... common stock for $2.28 per share in cash., ... in consultation with its financial and legal advisors, will ...
    ... Consulting, a division of Gallagher Benefit Services, Inc., today announced the ... which examines current employee benefit trends and strategies. , ... ... division of Gallagher Benefit Services, Inc., today announced the release of ...
    ... Advice on Lap-Band Gastric Banding Procedure--Hundreds of Thousands with 30 ... Loss and to Ease Weight-Related Symptoms Including Diabetes, High Blood ... and Sleep Apnea. , ... Dallas ...
    Cached Medicine News:Health News:Shanghai Medical Technology Co., Appoints Chief Financial Officer 2Health News:Shanghai Medical Technology Co., Appoints Chief Financial Officer 3Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 2Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 3Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 4Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 5Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 6Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 7Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 8Health News:Micromet, Inc. Reports Second Quarter 2008 Financial Results 9Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 2Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 3Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 4Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 5Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 6Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 7Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 8Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 9Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 10Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 11Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 12Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 13Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 14Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 15Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 16Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 17Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 18Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 19Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 20Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 21Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 22Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 23Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 24Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 25Health News:Cardinal Health Reports Fiscal 2008 Results, Provides Fiscal 2009 Outlook 26
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: